Thenalidine
 | |
| Clinical data | |
|---|---|
| ATC code |
D04AA03 (WHO) R06AX03 (WHO) R06AX53 (WHO) (combinations) |
| Identifiers | |
| |
| CAS Number |
86-12-4  Y |
| PubChem (CID) | 27901 |
| DrugBank |
DB04826 Y |
| ChemSpider |
25957  N |
| UNII |
6U94N2D00F Y |
| KEGG |
D07194 Y |
| ECHA InfoCard | 100.001.501 |
| Chemical and physical data | |
| Formula | C17H22N2S |
| Molar mass | 286.436 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| NY (what is this?) (verify) | |
Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug.[1] It was withdrawn from the US, Canadian, and UK markets in 1963 due to a risk of neutropenia.[2]
References
- ↑ Getzler, N. A.; Ereaux, L. P. (1959). "Evaluation of thenalidine tratrate (sandostene) in dermatological disorders". Canadian Medical Association journal. 80 (6): 445–448. PMC 1830689
. PMID 13629433. - ↑ "Thenalidine". DrugBank.
| Antihistamines for topical use | |
|---|---|
| Anesthetics for topical use | |
| Others |
|
| Aminoalkyl ethers |
|
|---|---|
| Substituted alkylamines | |
| Substituted ethylenediamines |
|
| Phenothiazine derivatives | |
| Piperazine derivatives | |
| Others for systemic use |
|
| For topical use | |
| Receptor (ligands) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (inhibitors) |
| ||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||
| Others |
| ||||||||||||||
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.